It started at thirteen, selling newspapers door to door in Duluth, Minnesota.
Watching how much that community relied on local news, I studied journalism at
York, then grew uneasy as big corporations swallowed small papers and the
internet gutted the industry. So I spent fourteen years trying to fix it.
When COVID hit, the problem was physical instead of digital, but the shape was
identical: something essential, and no domestic capacity to make it. We built the
factory. When foreign competitors dumped product below cost and the US Trade
Representative urged me to file an anti dumping case, I decided to out build them
instead. Automation and computer vision took the line from a hundred and twenty
people down to seven, and made the masks faster and better.
We don't need a bailout. We don't need other countries. We need full supply
chain control and no foreign dependence. Made in America, made in Texas.
Then the fulfillment layer turned out to be broken too, so that became a company.
The regulatory habits we had picked up making a medical device, lot tracking,
expiration control, inspecting every unit instead of sampling, turned out to be
exactly what other serious brands needed.
Pharmaceutical manufacturing was the best combination of digital, physical,
biological, and regulatory infrastructure I could find. So that is what I am
doing now.
Armbrust American went from raw plastic to finished masks. RonanRx goes from
patient biology to personalized medicine.